source
- FDA releases new manual outlining clinical pharmacology review practices for NDAs and BLAsThe U.S. Food and Drug Administration’s Office of Translational Sciences and Office of Clinical Pharmacology have issued a new manual of procedures and policies (MAPP).\n\nThe document sets out goo…
- FDA to call AI "super intelligence" in all official communicationsThe FDA announced that it will replace the term "artificial intelligence" with "super intelligence" in its official materials. The change applies to all correspondence, public communications, webs…